Original Research

Accepted on 21 Nov 2024

Development of a recombinant human IgG1 monoclonal antibody against the TRBV5-1 segment of the T cell receptor for the treatment of mature T cell neoplasms

in Cancer Immunity and Immunotherapy

Michele Pitaro
Giovanni Antonini
Alessandro Arcovito
Francesco Buccisano
Alfredo De Lauro
Maria Irno Consalvo
Valentina Gallo
Noah Giacon
Giuseppe Felice Mangiatordi
Maddalena Pacelli

Frontiers in Immunology

doi 10.3389/fimmu.2024.1520103

Original Research

Accepted on 21 Nov 2024

TLS and immune cell profiling: Immunomodulatory effects of immunochemotherapy on tumour microenvironment in resectable stage III NSCLC

in Cancer Immunity and Immunotherapy

Chaopin Yang
Jinqi You
Yizhi Wang
Si Chen
Yan Tang
Hao Chen
Haoran Zhong
Ruyue Song
Hao Long
Tong Xiang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1499731

Original Research

Accepted on 21 Nov 2024

m6A Methylation Profiling as a Prognostic Marker in Nasopharyngeal Carcinoma: Insights from MeRIP-Seq and RNA-Seq

in Cancer Immunity and Immunotherapy

Xiaochuan Chen
Wenqian Xu
Junping Pan
Hanxuan Yang
Yi Li
Xin Chen
Yingming Sun
Qinying Liu
Sufang Qiu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1492648

Original Research

Accepted on 21 Nov 2024

Innovative Strategies to Optimise Colorectal Cancer Immunotherapy through Molecular Mechanism Insights

in Cancer Immunity and Immunotherapy

Quanjun Lin
Zhiqiang Wang
Jue Wang
Ming Xu
Xinyi Zhang
Peng Sun
Yihang Yuan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1509658

Original Research

Accepted on 21 Nov 2024

Colorimetric Aptasensor Coupled with a Deep-learning Powered Smartphone app for Programmed Death Ligand-1 Expressing Extracellular Vesicles

in Cancer Immunity and Immunotherapy

Adeel Khan
Haroon Khan
Nongyue He
Zhiyang Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1479403

Opinion

Accepted on 21 Nov 2024

Exploring the Synergy Between Tumor Microenvironment Modulation and STING Agonists in Cancer Immunotherapy

in Cancer Immunity and Immunotherapy

Zongjiang Yu
Xiaoyan Qi
Meng Xiangwei

Frontiers in Immunology

doi 10.3389/fimmu.2024.1488345

Original Research

Accepted on 21 Nov 2024

Decoding the Prognostic Landscape of LUAD: The Interplay Between N6-methyladenosine Modification and Immune Microenvironment

in Cancer Immunity and Immunotherapy

Quan Chen
Weijun Wan
Qing Zhao
Juan Li
Yanli Xiong
Yuchuan Yuan
Lu Tang
Xiaofeng Wu
Wei Xing
Wei Guo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1514497

Original Research

Accepted on 21 Nov 2024

Chemo-free Salvage Treatment Outperforms Traditional Chemotherapy in Advanced Lines of Relapsed/Refractory Subcutaneous Panniculitis-like T-cell Lymphoma

in Cancer Immunity and Immunotherapy

Chao Chen
Jingjing Yin
Wei Wang
Danqing Zhao
Chong Wei
Congwei Jia
Wei Zhang
Daobin Zhou
Yan Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1476875

Original Research

Published on 21 Nov 2024

Global trends and research hotspots in perioperative management of lung cancer: a bibliometric analysis from 2004 to 2024

in Cancer Immunity and Immunotherapy

Qinling Jiang
Zhuheng Wei
Pingping Liu
Zonghuai Li
Huiqin Jiang
Yilin Cao
Bo Zhang
Yuanyuan Yan
Yulong He

Frontiers in Immunology

doi 10.3389/fimmu.2024.1500686

114 views

Original Research

Published on 21 Nov 2024

The mechanism of PDE7B inhibiting the development of hepatocellular carcinoma through oxidative stress

in Cancer Immunity and Immunotherapy

Yunfeng Luo
Huaide Gao
Jianghua Zhao
Lin Chen
Jianguo Shao
Linling Ju

Frontiers in Immunology

doi 10.3389/fimmu.2024.1469740

Systematic Review

Accepted on 20 Nov 2024

Efficacy and safety of adding immune checkpoint inhibitors to standard therapy for recurrent or advanced cervical cancer: A meta-analysis of phase 3 clinical trials

in Cancer Immunity and Immunotherapy

Xinmiao Zhang
Jinhai Shen
Mengfan Huang
Rongxia Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1507977

Review

Accepted on 20 Nov 2024

Leveraging the Synergy Between Anti-Angiogenic Therapy and Immune Checkpoint Inhibitors to Treat Digestive System Cancers

in Cancer Immunity and Immunotherapy

Qinlan Xu
Dong Shao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1487610

Original Research

Accepted on 20 Nov 2024

Immune-Related Diagnostic Markers for Benign Prostatic Hyperplasia and Their Potential as Drug Targets

in Cancer Immunity and Immunotherapy

YaXuan Wang
Jing Wang
Jibin Liu
Haixia Zhu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1516362

Correction

Accepted on 20 Nov 2024

Case Report: Long Remission and Survival Following Immunotherapy in a Case of Pulmonary Pleomorphic Carcinoma

in Cancer Immunity and Immunotherapy

Muyang Chen
Tongshan Wang
Anpeng Wang
Hao Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1530843

Systematic Review

Accepted on 20 Nov 2024

Comparison of the Efficacy and Safety of Perioperative Immunochemotherapeutic Strategies for locally advanced esophageal cancer: a Systematic Review and Network Meta-analysis

in Cancer Immunity and Immunotherapy

Jiao Zhang
Peixi Zhao
Rui Xu
Le Han
Wenjuan Chen
Yili Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1478377

Case Report

Accepted on 20 Nov 2024

A novel third-generation anti-CD19/CD22 CAR T-cells combined with auto-HSCT for relapsed Burkitt lymphoma

in Cancer Immunity and Immunotherapy

XIAODAN LUO
Ao Chen
Le Qin
Robert Weinkove
Rong Zhao
Ting Ye
Sihui Chen
Jianli Tang
Jianbo Liu
Jiayu Huang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1497736

Navigation group

Articles

Development of a recombinant human IgG1 monoclonal antibody against the TRBV5-1 segment of the T cell receptor for the treatment of mature T cell neoplasms

TLS and immune cell profiling: Immunomodulatory effects of immunochemotherapy on tumour microenvironment in resectable stage III NSCLC

m6A Methylation Profiling as a Prognostic Marker in Nasopharyngeal Carcinoma: Insights from MeRIP-Seq and RNA-Seq

Innovative Strategies to Optimise Colorectal Cancer Immunotherapy through Molecular Mechanism Insights

Colorimetric Aptasensor Coupled with a Deep-learning Powered Smartphone app for Programmed Death Ligand-1 Expressing Extracellular Vesicles

Exploring the Synergy Between Tumor Microenvironment Modulation and STING Agonists in Cancer Immunotherapy

Decoding the Prognostic Landscape of LUAD: The Interplay Between N6-methyladenosine Modification and Immune Microenvironment

Chemo-free Salvage Treatment Outperforms Traditional Chemotherapy in Advanced Lines of Relapsed/Refractory Subcutaneous Panniculitis-like T-cell Lymphoma

Global trends and research hotspots in perioperative management of lung cancer: a bibliometric analysis from 2004 to 2024

The mechanism of PDE7B inhibiting the development of hepatocellular carcinoma through oxidative stress

Efficacy and safety of adding immune checkpoint inhibitors to standard therapy for recurrent or advanced cervical cancer: A meta-analysis of phase 3 clinical trials

Leveraging the Synergy Between Anti-Angiogenic Therapy and Immune Checkpoint Inhibitors to Treat Digestive System Cancers

Immune-Related Diagnostic Markers for Benign Prostatic Hyperplasia and Their Potential as Drug Targets

Case Report: Long Remission and Survival Following Immunotherapy in a Case of Pulmonary Pleomorphic Carcinoma

Comparison of the Efficacy and Safety of Perioperative Immunochemotherapeutic Strategies for locally advanced esophageal cancer: a Systematic Review and Network Meta-analysis

A novel third-generation anti-CD19/CD22 CAR T-cells combined with auto-HSCT for relapsed Burkitt lymphoma